 |
市場調査レポート
商品コード
1454189
海洋バイオテクノロジーの世界市場規模、シェア、成長分析、製品別、用途別-産業予測、2024～2031年Global Marine Biotechnology Market Size, Share, Growth Analysis, By Product(Marine animal-derived products, marine plant-derived products), By Application(Healthcare and cosmetics, food and agriculture) - Industry Forecast 2024-2031 |
||||||
| 海洋バイオテクノロジーの世界市場規模、シェア、成長分析、製品別、用途別-産業予測、2024～2031年 |
|
出版日: 2024年03月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の海洋バイオテクノロジー市場規模は、2022年に58億米ドルと評価され、2023年の61億9,000万米ドルから2031年には104億9,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは6.80％で成長する展望です。
急速に拡大する世界の海洋バイオテクノロジー市場は、医療、農業、エネルギーなど多様なセグメントにおける革新的な製品開発のために、世界の海洋の豊富な資源を活用することに専念しています。その目標は、海洋生物のユニークな特質を活用して、治療、栄養補助食品、バイオ燃料など、先駆的なバイオテクノロジー製品を生み出すことです。持続可能で環境に優しいソリューションに対する需要の高まり、慢性疾患の蔓延、代替エネルギー源の必要性などに後押しされ、市場は高い研究開発コスト、海洋資源へのアクセス制限、規制上の障害などの課題に直面しています。それにもかかわらず、バイオテクノロジーとゲノミクスにおける最近の進歩は、産業界と研究機関との協力関係の増加と相まって、市場の成長を促進する態勢を整えています。注目すべき動向は、医療、組織工学、再生医療への応用が期待される海洋バイオマテリアルに重点が置かれるとともに、食品加工やバイオ燃料生産など様々な産業で海洋由来酵素の応用が拡大していることです。世界人口の拡大と持続可能性への要求の高まりにより、海洋バイオテクノロジー市場は進歩と創造性のための豊富な機会を提供すると予想されます。
目次
エグゼクティブサマリー
- 市場概要
- 繁栄と衰退
調査手法
- 情報調達
- セカンダリとプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
海洋バイオテクノロジーの世界市場：製品別
- 市場概要
- 海洋動物由来製品
- 海洋植物由来製品
- 海洋微生物由来製品
海洋バイオテクノロジーの世界市場：用途別
- 市場概要
- 医療と化粧品
- 食と農業
- 工業製品
- 研究開発
海洋バイオテクノロジーの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- BASF SE（ドイツ）
- CP Kelco（米国）
- Cyanotech Corporation（米国）
- DowDuPont Inc.（米国）
- FMC Corporation（米国）
- Lonza Group AG（スイス）
- Marinova Pty Ltd（オーストラリア）
- New England Biolabs Inc.（米国）
- Novozymes A/S（デンマーク）
- PML Applications Ltd（英国）
- PharmaMar S.A.（スペイン）
- Seppic（フランス）
- Solutex GC（スペイン）
- Sonneborn LLC（米国）
- The Lubrizol Corporation（米国）
- The Scottish Association for Marine Science（英国）
- Thermo Fisher Scientific Inc.（米国）
- Tiger Brands Limited（南アフリカ）
- Unilever NV（オランダ）
- Xiamen Kingdomway Group Co. Ltd.（中国）
Global Marine Biotechnology Market size was valued at USD 5.8 billion in 2022 and is poised to grow from USD 6.19 billion in 2023 to USD 10.49 billion by 2031, growing at a CAGR of 6.80% during the forecast period (2024-2031).
The rapidly expanding global marine biotechnology market is dedicated to harnessing the abundant resources of the world's oceans for innovative product development across diverse sectors such as medicine, agriculture, and energy. Its goal is to leverage the unique qualities of marine organisms to create pioneering biotechnological products, including therapeutics, nutraceuticals, and biofuels. Fueled by the escalating demand for sustainable and environmentally friendly solutions, the prevalence of chronic diseases, and the imperative for alternative energy sources, the market faces challenges like high research and development costs, restricted access to marine resources, and regulatory obstacles. Nonetheless, recent strides in biotechnology and genomics, coupled with increased collaborations between industry and research entities, are poised to propel market growth. A notable trend is the rising application of marine-derived enzymes in various industries, such as food processing and biofuel production, alongside a growing emphasis on marine biomaterials with potential applications in medicine, tissue engineering, and regenerative medicine. With the global population expanding and a heightened demand for sustainability, the marine biotechnology market is anticipated to offer abundant opportunities for advancement and creativity.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Marine Biotechnology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Marine Biotechnology Market Segmental Analysis
Global Marine Biotechnology Market is segmented on the basis of product, application, and region. By product, the market is segmented marine animal-derived products, marine plant-derived products, and marine microbial-derived products. By application, the market is segmented into healthcare and cosmetics, food and agriculture, industrial products, and research and development. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Marine Biotechnology Market
The escalating awareness of environmental issues and the emphasis on sustainability have led to an increasing desire for eco-friendly products across diverse sectors. Marine biotechnology provides a spectrum of sustainable solutions, including the utilization of marine-derived enzymes for industrial purposes, the development of biofuels, and the creation of bioplastics. One notable example is Algix, a company that manufactures bioplastic materials from algae, presenting biodegradable and sustainable options as alternatives to conventional plastic materials.
Restraints in the Global Marine Biotechnology Market
The advancement of marine biotechnology products requires substantial research and development efforts, encompassing the discovery and nurturing of marine organisms, along with the extraction and refinement of bioactive compounds. The substantial expenses linked to these procedures can impede the expansion and market integration of marine biotechnology products. To illustrate, the cultivation and extraction of a singular marine-derived compound, such as a natural product, may incur costs reaching several hundred thousand dollars.
Market Trends of the Global Marine Biotechnology Market
The marine biotechnology market is witnessing a rising trend in the utilization of biomaterials derived from the ocean, holding promise for diverse applications in medicine, tissue engineering, and regenerative medicine. A notable example is the exploration of marine collagen, which exhibits superior properties in comparison to its mammalian counterpart. Researchers are actively investigating the potential of marine collagen as a biomaterial for applications such as wound healing and tissue regeneration, showcasing the expanding horizons of marine-derived compounds in cutting-edge biomedical advancements.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Marine Biotechnology Market by Product
- Market Overview
- Marine animal-derived products
- marine plant-derived products
- and marine microbial-derived products
Global Marine Biotechnology Market by Application
- Market Overview
- Healthcare and cosmetics
- food and agriculture
- industrial products
- and research and development
Global Marine Biotechnology Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CP Kelco (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cyanotech Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DowDuPont Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- FMC Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Marinova Pty Ltd (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- New England Biolabs Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novozymes A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PML Applications Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PharmaMar S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Seppic (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Solutex GC (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sonneborn LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- The Lubrizol Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- The Scottish Association for Marine Science (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tiger Brands Limited (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Unilever NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Xiamen Kingdomway Group Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
